We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00413114
First Posted: December 19, 2006
Last Update Posted: August 26, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Gemin X )
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: August 16, 2013
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):